Shenzhen Core Medical Technology Co.,ltd.
Clinical trials sponsored by Shenzhen Core Medical Technology Co.,ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart pump could be lifeline for failing hearts Results expected Dec 2026 (estimated)
- New heart pump could offer lifeline for right heart failure patients Results expected Dec 2026 (estimated)
-
New heart pump trial offers hope for End-Stage heart failure patients
Disease control OngoingThis trial is testing a new mechanical heart pump called the Corheart 6 in 50 people with end-stage heart failure. The pump is implanted to help the heart circulate blood. Researchers are checking if the device works safely and effectively at 3 months and 2 years after implantati…
Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New heart pump takes on ECMO in High-Stakes stenting trial
Disease control OngoingThis study tests a new temporary heart pump called CorVad against the standard ECMO machine in 262 high-risk patients who need complex heart stenting. The goal is to see which device better keeps the heart stable during the procedure and reduces complications like death, stroke, …
Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC